Evidence check: Testosteron Test in the context of Wechseljahre

The question about testosterone testing in menopause is understandable, but the evidence is weak. Testosterone levels decline in women during menopause, yet there are no standardized reference ranges or clinical guidelines recommending routine testing. Direct-to-consumer (DTC) hormone tests for testosterone are often unvalidated and can be confounded by circadian variation, hormone therapy, or lab differences. Most studies on testosterone in menopause are observational and show no clear benefit for diagnosing or managing symptoms like fatigue or low libido. A standalone test is not clinically actionable; a physician's evaluation including symptoms and other hormones is essential. MyBody-X does not offer a specific testosterone test for menopause; its products focus on DNA-based analyses with low predictive power. Beware of marketing claims: a hormone test does not replace medical assessment. Evidence grade: unclear, based on general DTC limitations.